Pieper DR, Al-Mefty O, Hanada Y, Buechner D (1999) Hyperostosis associated with meningioma of the cranial base: secondary changes or tumor invasion. Neurosurgery 44:742–746. https://doi.org/10.1097/00006123-199904000-00028

Article  CAS  PubMed  Google Scholar 

Talacchi A, Corsini F, Gerosa M (2011) Hyperostosing meningiomas of the cranial vault with and without tumor mass. Acta Neurochir (Wien) 153:53–61. https://doi.org/10.1007/s00701-010-0838-8

Article  PubMed  Google Scholar 

Thomann P, Hani L, Vulcu S, Schutz A, Frosch M, Jesse CM, El-Koussy M, Soll N, Hakim A, Raabe A, Schucht P (2022) Natural history of meningiomas: a serial volumetric analysis of 240 tumors. J Neurosurg 137:1639–1649. https://doi.org/10.3171/2022.3.JNS212626

Article  PubMed  Google Scholar 

Kaur G, Sayegh ET, Larson A, Bloch O, Madden M, Sun MZ, Barani IJ, James CD, Parsa AT (2014) Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro Oncol 16:628–636. https://doi.org/10.1093/neuonc/nou025

Article  PubMed  PubMed Central  Google Scholar 

Takeuchi K, Kawabata S, Hiramatsu R, Matsushita Y, Tanaka H, Sakurai Y, Suzuki M, Ono K, Miyatake SI, Kuroiwa T (2018) Boron Neutron Capture Therapy for High-Grade Skull-Base Meningioma. J Neurol Surg B Skull Base 79:S322–S327. https://doi.org/10.1055/s-0038-1666837

Article  PubMed  PubMed Central  Google Scholar 

Chen WC, Lucas CG, Magill ST, Rogers CL, Raleigh DR (2023) Radiotherapy and radiosurgery for meningiomas. Neurooncol Adv 5:i67–i83. https://doi.org/10.1093/noajnl/vdac088

Article  PubMed  PubMed Central  Google Scholar 

Ware ML, Larson DA, Sneed PK, Wara WW, McDermott MW (2004) Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma. Neurosurgery 54:55–63. https://doi.org/10.1227/01.neu.0000097199.26412.2a

Article  PubMed  Google Scholar 

Hilton DA, Shivane A, Kirk L, Bassiri K, Enki DG, Hanemann CO (2016) Activation of multiple growth factor signalling pathways is frequent in meningiomas. Neuropathology 36:250–261. https://doi.org/10.1111/neup.12266

Article  CAS  PubMed  Google Scholar 

Johnson MD, O’Connell MJ, Vito F, Pilcher W (2009) Bone morphogenetic protein 4 and its receptors are expressed in the leptomeninges and meningiomas and signal via the Smad pathway. J Neuropathol Exp Neurol 68:1177–1183. https://doi.org/10.1097/NEN.0b013e3181bc6642

Article  CAS  PubMed  Google Scholar 

Nordqvist AC, Mathiesen T (2002) Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness. J Neurooncol 57:19–26. https://doi.org/10.1023/a:1015765613544

Article  PubMed  Google Scholar 

Pagotto U, Arzberger T, Hopfner U, Sauer J, Renner U, Newton CJ, Lange M, Uhl E, Weindl A, Stalla GK (1995) Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growth. J Clin Invest 96:2017–2025. https://doi.org/10.1172/JCI118249

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen E, Leclair NK, Herlth K, Soucy M, Renzette N, Zhuo X, Kelly K, Omerza G, Onyiuke H, McNeill I, Wolansky L, Becker K, Li L, Wu Q, Bulsara KR (2023) DNA methylation provides diagnostic value for meningioma recurrence in clinical practice. Acta Neurochir (Wien) 165:1323–1331. https://doi.org/10.1007/s00701-023-05550-5

Article  PubMed  Google Scholar 

Vaubel RA, Kumar R, Weiskittel TM, Jenkins S, Dasari S, Uhm JH, Lachance DH, Brown PD, Van Gompel JJ, Jenkins RB, Kipp BR, Sukov WR, Giannini C, Johnson DR, Raghunathan A (2023) Genomic markers of recurrence risk in atypical meningioma following gross total resection. Neurooncol Adv 5:vdad004. https://doi.org/10.1093/noajnl/vdad004

Article  PubMed  PubMed Central  Google Scholar 

Liu X, Krawczyk E, Suprynowicz FA, Palechor-Ceron N, Yuan H, Dakic A, Simic V, Zheng YL, Sripadhan P, Chen C, Lu J, Hou TW, Choudhury S, Kallakury B, Tang DG, Darling T, Thangapazham R, Timofeeva O, Dritschilo A, Randell SH, Albanese C, Agarwal S, Schlegel R (2017) Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens. Nat Protoc 12:439–451. https://doi.org/10.1038/nprot.2016.174

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanvitale CE, Kerr G, Chaikuad A, Ramel MC, Mohedas AH, Reichert S, Wang Y, Triffitt JT, Cuny GD, Yu PB, Hill CS, Bullock AN (2013) A new class of small molecule inhibitor of BMP signaling. PLoS ONE 8:e62721. https://doi.org/10.1371/journal.pone.0062721

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Viaene AN, Zhang B, Martinez-Lage M, Xiang C, Tosi U, Thawani JP, Gungor B, Zhu Y, Roccograndi L, Zhang L, Bailey RL, Storm PB, O’Rourke DM, Resnick AC, Grady MS, Dahmane N (2019) Transcriptome signatures associated with meningioma progression. Acta Neuropathol Commun 7:67. https://doi.org/10.1186/s40478-019-0690-x

Article  PubMed  PubMed Central  Google Scholar 

Behling F, Fodi C, Gepfner-Tuma I, Kaltenbach K, Renovanz M, Paulsen F, Skardelly M, Honegger J, Tatagiba M, International Consortium on M, Schittenhelm J, Tabatabai G (2021) H3K27me3 loss indicates an increased risk of recurrence in the Tubingen meningioma cohort. Neuro Oncol 23:1273–1281. https://doi.org/10.1093/neuonc/noaa303

Article  Google Scholar 

Cerda Nicolas M (1992) Meningiomas: morphologic and ultrastructural characteristics of psammoma bodies. Arch Neurobiol (Madr) 55:256–261

CAS  PubMed  Google Scholar 

Das DK (2009) Psammoma body: a product of dystrophic calcification or of a biologically active process that aims at limiting the growth and spread of tumor? Diagn Cytopathol 37:534–541. https://doi.org/10.1002/dc.21081

Article  PubMed  Google Scholar 

Kubota T, Yamashima T, Hasegawa M, Kida S, Hayashi M, Yamamoto S (1986) Formation of psammoma bodies in meningocytic whorls. Ultrastructural study and analysis of calcified material. Acta Neuropathol 70:262–268. https://doi.org/10.1007/BF00686081

Article  CAS  PubMed  Google Scholar 

Lin Z, Zhao M, Ren X, Wang J, Li Z, Chen X, Wang Y, Li X, Wang C, Jiang Z (2017) Clinical Features, Radiologic Findings, and Surgical Outcomes of 65 Intracranial Psammomatous Meningiomas. World Neurosurg 100:395–406. https://doi.org/10.1016/j.wneu.2017.01.056

Article  PubMed  Google Scholar 

Di Cristofori A, Del Bene M, Locatelli M, Boggio F, Ercoli G, Ferrero S, Del Gobbo A (2018) Meningioma and Bone Hyperostosis: Expression of Bone Stimulating Factors and Review of the Literature. World Neurosurg 115:e774–e781. https://doi.org/10.1016/j.wneu.2018.04.176

Article  PubMed  Google Scholar 

Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685–700. https://doi.org/10.1016/s0092-8674(03)00432-x

Article  CAS  PubMed  Google Scholar 

Itoh F, Watabe T, Miyazono K (2014) Roles of TGF-beta family signals in the fate determination of pluripotent stem cells. Semin Cell Dev Biol 32:98–106. https://doi.org/10.1016/j.semcdb.2014.05.017

Article  CAS  PubMed  Google Scholar 

Kishigami S, Mishina Y (2005) BMP signaling and early embryonic patterning. Cytokine Growth Factor Rev 16:265–278. https://doi.org/10.1016/j.cytogfr.2005.04.002

Article  CAS  PubMed  Google Scholar 

Nolan K, Kattamuri C, Luedeke DM, Deng X, Jagpal A, Zhang F, Linhardt RJ, Kenny AP, Zorn AM, Thompson TB (2013) Structure of protein related to Dan and Cerberus: insights into the mechanism of bone morphogenetic protein antagonism. Structure 21:1417–1429. https://doi.org/10.1016/j.str.2013.06.005

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nolan K, Kattamuri C, Rankin SA, Read RJ, Zorn AM, Thompson TB (2016) Structure of Gremlin-2 in Complex with GDF5 Gives Insight into DAN-Family-Mediated BMP Antagonism. Cell Rep 16:2077–2086. https://doi.org/10.1016/j.celrep.2016.07.046

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pytliak M, Vargova V, Mechirova V, Felsoci M (2011) Serotonin receptors - from molecular biology to clinical applications. Physiol Res 60:15–25

Article  CAS  PubMed  Google Scholar 

Campisi J, Kapahi P, Lithgow GJ, Melov S, Newman JC, Verdin E (2019) From discoveries in ageing research to therapeutics for healthy ageing. Nature 571:183–192. https://doi.org/10.1038/s41586-019-1365-2

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Talari NK, Panigrahi M, Madigubba S, Challa S, Phanithi PB (2016) Altered tryptophan metabolism in human meningioma. J Neurooncol 130:69–77. https://doi.org/10.1007/s11060-016-2225-7

Article  CAS  PubMed  Google Scholar 

Masalha W, Daka K, Woerner J, Pompe N, Weber S, Delev D, Kruger MT, Schnell O, Beck J, Heiland DH, Grauvogel J (2021) Metabolic alterations in meningioma reflect the clinical course. BMC Cancer 21:211. https://doi.org/10.1186/s12885-021-07887-5

Article  CAS  PubMed  PubMed Central  Google Scholar